Menu

Life Sciences

Insightful, customized solutions for innovative business leaders

In today’s fast-paced marketplace and complicated regulatory environment, operating in the life sciences industry can bring a variety of challenges. From raising and managing capital to protecting intellectual property and prioritizing research and development efforts, you require business advisors who understand your complex issues and the specific business problems you might face.

Recommended Insight

WHITE PAPER

Changes to revenue recognition in the life sciences industry

A white paper about how entities in the life sciences industry may be affected by the new revenue recognition guidance in ASC 606.

What life sciences boards need to understand about corruption risk

INSIGHT ARTICLE

What life sciences boards need to understand about corruption risk

Learn what the board and others who have executive oversight of life sciences companies need to understand about minimizing corruption risk.

INSIGHT ARTICLE

Understanding R&D credit benefits for the life sciences industry

Resources to help you gain an understanding of the eligibility criteria and re-examine your eligibility for the R&D credit.

INSIGHT ARTICLE

Mass. court holds biotech firm engaged in substantial manufacturing

California biotech firm sees larger corporate tax bill after Massachusetts high court determination that it was engaged in manufacturing.

INSIGHT ARTICLE

Improvements to employee share-based payment accounting

Learn about improvements to the share-based compensation standard and its impact on the life sciences industry.

INSIGHT ARTICLE

The benefits of finance and accounting outsourcing for life sciences

Learn how growing life sciences companies leverage finance and accounting outsourcing to enhance the finance function and focus on core competencies.

WHITE PAPER

Anti-inversion legislation could affect middle market companies

While large public company inversions have received the press coverage, middle market and private companies can invert and achieve similar benefits.

WHITE PAPER

Finance transformation in the pharmaceutical industry

Commercializing new drugs is more challenging than ever, but increasing focus on your finance function can better manage a difficult business model.

Contact Our Team

John Lanza
Partner,
National Practice Leader

800.274.3978
John.Lanza@rsmus.com